Helius Medical Technologies

Neurotech company (Nasdaq: HSDT)

Acerca de Helius Medical Technologies

Fundado2014

Helius is a leading neurotechnology company in the medical device field, specializing in utilizing non-implantable platform technologies to treat neurological deficits, enhance the brain's compensatory abilities, and promote neuroplasticity, thereby improving the lives of patients with neurological disorders. The company has announced the establishment of the SOL Treasury.

Comunidad
LinkedIn
Website
Etiquetas
Publicly listed company
Crypto Stocks

Tendencia de cambio del índice de popularidad

Miembros del equipo

Dane C. Andreeff
Dane C. Andreeff

President and Chief Executive Officer

Jeffrey S. Mathiesen
Jeffrey S. Mathiesen

Chief Financial Officer

Inversores

Pantera Capital
Pantera Capital
Summer Capital
Summer Capital

Detalles de la recaudación de fondos

Post-IPO(2025-09-14)
Cantidad€433,75M
Inversores
Pantera Capital
Pantera Capital
Summer Capital
Summer Capital
Valuación--